Insulin Glargine (U-100) Cartridge Systems and Pens and LarkaDrin Capsules
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and LarkaDrin Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: acetaminophen / dichloralphenazone / isometheptene mucate
Brand name: Nodolor
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Laronidase
- Insulin Glargine (U-100) Cartridge Systems and Pens-Laronidase Intravenous
- Insulin Glargine (U-100) Cartridge Systems and Pens-Larotrectinib
- Insulin Glargine (U-100) Cartridge Systems and Pens-Larotrectinib Capsules
- Insulin Glargine (U-100) Cartridge Systems and Pens-Larotrectinib Oral Solution
- Insulin Glargine (U-100) Cartridge Systems and Pens-Larotrectinib Sulfate
- LarkaDrin Capsules-Insulin Glargine (U-100) Vials
- LarkaDrin Capsules-Insulin Glargine (U-300) Pens
- LarkaDrin Capsules-Insulin glargine and lixisenatide
- LarkaDrin Capsules-Insulin glargine and lixisenatide Subcutaneous
- LarkaDrin Capsules-Insulin glargine, recombinant Subcutaneous
- LarkaDrin Capsules-Insulin glulisine